Literature DB >> 35039860

Estimating Tuberculosis Transmission Risks in a Primary Care Clinic in South Africa: Modeling of Environmental and Clinical Data.

Kathrin Zürcher1, Julien Riou1, Carl Morrow2,3, Marie Ballif1, Anastasia Koch4, Simon Bertschinger1,5, Digby F Warner2,4, Keren Middelkoop2,3, Robin Wood2,3, Matthias Egger1,6,7, Lukas Fenner1.   

Abstract

BACKGROUND: Congregate settings, such as healthcare clinics, may play an essential role in Mycobacterium tuberculosis (Mtb) transmission. Using patient and environmental data, we studied transmission at a primary care clinic in South Africa.
METHODS: We collected patient movements, cough frequency, and clinical data, and measured indoor carbon dioxide (CO2) levels, relative humidity, and Mtb genomes in the air. We used negative binomial regression model to investigate associations.
RESULTS: We analyzed 978 unique patients who contributed 14 795 data points. The median patient age was 33 (interquartile range [IQR], 26-41) years, and 757 (77.4%) were female. Overall, median CO2 levels were 564 (IQR 495-646) parts per million and were highest in the morning. Median number of coughs per day was 466 (IQR, 368-503), and overall median Mtb DNA copies/μL/day was 4.2 (IQR, 1.2-9.5). We found an increased presence of Mtb DNA in the air of 32% (95% credible interval, 7%-63%) per 100 additional young adults (aged 15-29 years) and 1% (0-2%) more Mtb DNA per 10% increase of relative humidity. Estimated cumulative transmission risks for patients attending the clinic monthly for at least 1 hour range between 9% and 29%.
CONCLUSIONS: We identified young adults and relative humidity as potentially important factors for transmission risks in healthcare clinics. Our approach should be used to detect transmission and evaluate infection control interventions.
© The Author(s) 2022. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Mycobacterium tuberculosis; biosampling; carbon dioxide; cough; humidity; infection control; intervention; primary care clinic; transmission; tuberculosis

Mesh:

Substances:

Year:  2022        PMID: 35039860      PMCID: PMC9071349          DOI: 10.1093/infdis/jiab534

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   7.759


  43 in total

Review 1.  Recommendations on modern contact investigation methods for enhancing tuberculosis control.

Authors:  V J Cook; L Shah; J Gardy; A-C Bourgeois
Journal:  Int J Tuberc Lung Dis       Date:  2011-12-02       Impact factor: 2.373

2.  Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals.

Authors:  Yuan Liu; Zhi Ning; Yu Chen; Ming Guo; Yingle Liu; Nirmal Kumar Gali; Li Sun; Yusen Duan; Jing Cai; Dane Westerdahl; Xinjin Liu; Ke Xu; Kin-Fai Ho; Haidong Kan; Qingyan Fu; Ke Lan
Journal:  Nature       Date:  2020-04-27       Impact factor: 49.962

3.  Outcomes, infectiousness, and transmission dynamics of patients with extensively drug-resistant tuberculosis and home-discharged patients with programmatically incurable tuberculosis: a prospective cohort study.

Authors:  Keertan Dheda; Jason D Limberis; Elize Pietersen; Jody Phelan; Aliasgar Esmail; Maia Lesosky; Kevin P Fennelly; Julian Te Riele; Barbara Mastrapa; Elizabeth M Streicher; Tania Dolby; Abdallah M Abdallah; Fathia Ben-Rached; John Simpson; Liezel Smith; Tawanda Gumbo; Paul van Helden; Frederick A Sirgel; Ruth McNerney; Grant Theron; Arnab Pain; Taane G Clark; Robin M Warren
Journal:  Lancet Respir Med       Date:  2017-01-19       Impact factor: 30.700

4.  Antiretroviral therapy and TB notification rates in a high HIV prevalence South African community.

Authors:  Keren Middelkoop; Linda-Gail Bekker; Landon Myer; Leigh F Johnson; Matthew Kloos; Carl Morrow; Robin Wood
Journal:  J Acquir Immune Defic Syndr       Date:  2011-03-01       Impact factor: 3.731

5.  Cough-independent production of viable Mycobacterium tuberculosis in bioaerosol.

Authors:  Benjamin Patterson; Wayne Bryden; Charles Call; Andrea McKerry; Bryan Leonard; Ronnett Seldon; Melitta Gqada; Ryan Dinkele; Sophia Gessner; Digby F Warner; Robin Wood
Journal:  Tuberculosis (Edinb)       Date:  2020-12-08       Impact factor: 3.131

6.  Burden of new and recurrent tuberculosis in a major South African city stratified by age and HIV-status.

Authors:  Robin Wood; Stephen D Lawn; Judy Caldwell; Richard Kaplan; Keren Middelkoop; Linda-Gail Bekker
Journal:  PLoS One       Date:  2011-10-10       Impact factor: 3.240

7.  Correction: Seeing the "Big" Picture: Big Data Methods for Exploring Relationships Between Usage, Language, and Outcome in Internet Intervention Data.

Authors:  Jordan Carpenter; Patrick Crutchley; Ran D Zilca; H Andrew Schwartz; Laura K Smith; Angela M Cobb; Acacia C Parks
Journal:  J Med Internet Res       Date:  2017-12-19       Impact factor: 5.428

8.  Bioaerosol sampling for SARS-CoV-2 in a referral center with critically ill COVID-19 patients March-May 2020.

Authors:  Morgan A Lane; Erik A Brownsword; Ahmed Babiker; Jessica M Ingersoll; Jesse Waggoner; Marie Ayers; Matthew Klopman; Timothy M Uyeki; William G Lindsley; Colleen S Kraft
Journal:  Clin Infect Dis       Date:  2021-01-28       Impact factor: 9.079

9.  The infectiousness of tuberculosis patients coinfected with HIV.

Authors:  A Roderick Escombe; David A J Moore; Robert H Gilman; William Pan; Marcos Navincopa; Eduardo Ticona; Carlos Martínez; Luz Caviedes; Patricia Sheen; Armando Gonzalez; Catherine J Noakes; Jon S Friedland; Carlton A Evans
Journal:  PLoS Med       Date:  2008-09-16       Impact factor: 11.069

10.  Real-Time Investigation of Tuberculosis Transmission: Developing the Respiratory Aerosol Sampling Chamber (RASC).

Authors:  Robin Wood; Carl Morrow; Clifton E Barry; Wayne A Bryden; Charles J Call; Anthony J Hickey; Charles E Rodes; Thomas J Scriba; Jonathan Blackburn; Chacha Issarow; Nicola Mulder; Jeremy Woodward; Atica Moosa; Vinayak Singh; Valerie Mizrahi; Digby F Warner
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.